Literature DB >> 24449233

Successful treatment with imatinib in a patient with chronic eosinophilic leukemia not otherwise specified.

Alessandra Iurlo1, Nicola Stefano Fracchiolla, Valeria Ferla, Ramona Cassin, Enrico Gottardi, Alessandro Beghini, Umberto Gianelli, Orietta Spinelli, Agostino Cortelezzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24449233     DOI： 10.1200/JCO.2012.48.0665

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Pharmacokinetics interaction between imatinib and genistein in rats.

Authors:  Zhe Wang; Li Wang; Meng-Ming Xia; Wei Sun; Cheng-Ke Huang; Xiao Cui; Guo-Xin Hu; Qing-Quan Lian; Zeng-Shou Wang
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

2.  Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response.

Authors:  Alessandra Iurlo; Umberto Gianelli; Alessandro Beghini; Orietta Spinelli; Nicola Orofino; Francesca Lazzaroni; Stefano Cambiaghi; Tamara Intermesoli; Alessandro Rambaldi; Agostino Cortelezzi
Journal:  Oncotarget       Date:  2014-07-15

Review 3.  Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned.

Authors:  Javier Pinilla-Ibarz; Kendra L Sweet; Gabriela M Corrales-Yepez; Rami S Komrokji
Journal:  Onco Targets Ther       Date:  2016-08-10       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.